Keyphrases
Tumor
100%
Salivary Gland
100%
Primary Sarcoma
100%
University of Texas
50%
Survival Rate
50%
Sarcoma
50%
Cell Tumor
50%
Adjuvant Therapy
50%
Poor Prognosis
50%
Surgical Resection
50%
MD Anderson Cancer Center
50%
Treatment Modalities
50%
Clinical Prognosis
50%
Distant Metastasis
50%
Recurrence Rate
50%
Parotid Gland
50%
Mesenchymal Cells
50%
10-year Survival
50%
T1 Tumor
50%
Mesenchymal Malignancy
50%
Medicine and Dentistry
Neoplasm
100%
Salivary Gland
100%
Connective Tissue Cancer
100%
Recurrent Disease
66%
Malignant Neoplasm
33%
Survival Rate
33%
Cancer
33%
Surgery
33%
Adjuvant Therapy
33%
Distant Metastasis
33%
Parotid Gland
33%
Mesenchymoma
33%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Connective Tissue Cancer
100%
Recurrent Disease
66%
Malignant Neoplasm
33%
Survival Rate
33%
Distant Metastasis
33%
Mesenchymoma
33%